Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

• Autors principals: Macarena Orejudo (Autor), Raul R. Rodrigues-Diez (Autor), Raquel Rodrigues-Diez (Autor), Ana Garcia-Redondo (Autor), Laura Santos-Sánchez (Autor), Javier Rández-Garbayo (Autor), Pablo Cannata-Ortiz (Autor), Adrian M. Ramos (Autor), Alberto Ortiz (Autor), Rafael Selgas (Autor), Sergio Mezzano (Autor), Carolina Lavoz (Autor), Marta Ruiz-Ortega (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Hypertension is now considered as an inflammatory disease, and the kidney is a key end-organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a promising therapeutic target in immune and chronic inflammatory diseases, including hypertension and kidney disease. Eleva...